J. E. Davis - 01 Jun 2026 Form 4 Insider Report for QUEST DIAGNOSTICS INC (DGX)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
02 Jun 2026, 18:38:38 UTC
Prior SEC filing
06 Mar 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Sean D. Mersten, Attorney in Fact for James E. Davis

Key filing fact

J. E. Davis filed Form 4 for QUEST DIAGNOSTICS INC (DGX) on 02 Jun 2026.

Key facts

  • This page summarizes J. E. Davis's Form 4 filing for QUEST DIAGNOSTICS INC (DGX).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 02 Jun 2026, 18:38.

Change

  • Previous filing in this sequence was filed on 06 Mar 2026.
  • Current net transaction value: -$1,941,400.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001599837 Primary reporting owner

Davis J. E.

Relationship
CEO and President, Director
Address
500 PLAZA DRIVE, SECAUCUS
Signature
Sean D. Mersten, Attorney in Fact for James E. Davis
Signature date
02 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

DGX transaction

Common Stock

Sale

Transaction value
$1,941,400
Shares
-10,000
Change %
-7%
Price
$194.14
Shares after
132,423
Date
01 Jun 2026
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 1 footnote

Footnote F1

The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .